3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Interventions
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
14
Cyclophosphamide
9
Prednisone
8
Etoposide
6
Vincristine
5
Gemcitabine
5
Lenalidomide
4
Doxorubicin
4
Dexamethasone
3
Azacitidine
3
liposomal doxorubicin
2
endostar protein
2
apatinib
2
VAP-cyclo protocol
2
Ifosfamide
2
Cisplatin
2
sintilimab
1
romidepsin
1
ivarmacitinib
1
fludarabine phosphate
1
fludarabine
1
camrelizumab
1
Vinorelbine
1
Valproic Acid
1
Transplantation, Autologous
1
TQ-B3525
1
Rituximab
1
Prednisolone
1
Polymerase Chain Reaction
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, T-Cell, Peripheral
×
Flavin-Adenine Dinucleotide
×
Clear all
NCT00840385
2010-09-15
FAD
Fudan University
Phase 2
Unknown
30 enrolled